Pharmaceutical Companies Advance Research Into Vaccines, Therapies For Novel Coronavirus; Questions Around Access To Potential Vaccine Remain

ABC (Australia): When coronavirus vaccine is released, there won’t be enough to go around. Who will get it first? (Uibu, 6/9).

HealthDay News: HealthDay Reports: Experts Optimistic in Search for COVID-19 Vaccine (Gordon, 6/8).

The Hill: Inside the race to map the coronavirus (Wilson, 6/9).

Homeland Preparedness News: Reps. Kuster, Jeffries introduce bill to ensure mass production of COVID-19 vaccine (Kovaleski, 6/8).

New York Times: Can a Vaccine for Covid-19 Be Developed in Record Time? (Mukherjee et al., 6/8).

Project Syndicate/Econ Films: The Race for a Vaccine (6/8).

Reuters: Gilead’s remdesivir shows promise in COVID-19 study on monkeys (Mishra, 6/9).

Reuters: AstraZeneca wins fresh U.S. backing in race for COVID-19 treatment (Aripaka, 6/9).

Reuters: Explainer: What are antibody therapies and who is developing them for COVID-19? (Erman, 6/9).

Reuters: E.U. watchdog aims for speedy approval of remdesivir as COVID-19 treatment (Aripaka, 6/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.